Edition:
United Kingdom

Oramed Pharmaceuticals Inc (ORMP.OQ)

ORMP.OQ on NASDAQ Stock Exchange Capital Market

7.54USD
16 Feb 2018
Change (% chg)

$-0.20 (-2.58%)
Prev Close
$7.74
Open
$7.69
Day's High
$7.76
Day's Low
$7.54
Volume
2,137
Avg. Vol
9,102
52-wk High
$11.34
52-wk Low
$5.85

Select another date:

Tue, Nov 14 2017

BRIEF-Oramed receives approval for clinical study to treat NASH

* Oramed receives regulatory approval to conduct clinical study for treatment of NASH with its oral insulin capsule

BRIEF-Oramed pharmaceuticals ‍concludes its meeting with U.S. FDA regarding its oral insulin formulation​

* ‍Concluded its meeting with U.S. FDA regarding ORMD-0801, company's novel oral insulin formulation​

Select another date: